Giovannoni G, et al. Treatment outcomes of daclizumab in patients at high risk of transitioning to secondary progressive multiple sclerosis in DECIDE. EAN 2107, O2113.
MR CLEAN studie wint Wetenschaps- en Innovatieprijs 2017
mrt 2017 | Neuro-vasculair